JP2001335598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001335598A5 JP2001335598A5 JP2001084088A JP2001084088A JP2001335598A5 JP 2001335598 A5 JP2001335598 A5 JP 2001335598A5 JP 2001084088 A JP2001084088 A JP 2001084088A JP 2001084088 A JP2001084088 A JP 2001084088A JP 2001335598 A5 JP2001335598 A5 JP 2001335598A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- protein
- sequence represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 218
- 102000004169 proteins and genes Human genes 0.000 description 110
- 108090000623 proteins and genes Proteins 0.000 description 110
- 150000001413 amino acids Chemical class 0.000 description 52
- 229930182558 Sterol Natural products 0.000 description 49
- 150000003432 sterols Chemical class 0.000 description 49
- 235000003702 sterols Nutrition 0.000 description 49
- 150000003839 salts Chemical class 0.000 description 47
- 238000007792 addition Methods 0.000 description 28
- 238000012217 deletion Methods 0.000 description 28
- 230000037430 deletion Effects 0.000 description 28
- 238000006467 substitution reaction Methods 0.000 description 28
- 238000000034 method Methods 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 7
- 238000012216 screening Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000004770 neurodegeneration Effects 0.000 description 3
- 208000015122 neurodegenerative disease Diseases 0.000 description 3
- 201000001119 neuropathy Diseases 0.000 description 3
- 230000007823 neuropathy Effects 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 208000033808 peripheral neuropathy Diseases 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000003815 intracellular cholesterol transport Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001084088A JP2001335598A (ja) | 2000-03-24 | 2001-03-23 | 新規タンパク質、その製造法および用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-88595 | 2000-03-24 | ||
| JP2000088595 | 2000-03-24 | ||
| JP2001084088A JP2001335598A (ja) | 2000-03-24 | 2001-03-23 | 新規タンパク質、その製造法および用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001335598A JP2001335598A (ja) | 2001-12-04 |
| JP2001335598A5 true JP2001335598A5 (enExample) | 2008-05-08 |
Family
ID=26588558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001084088A Pending JP2001335598A (ja) | 2000-03-24 | 2001-03-23 | 新規タンパク質、その製造法および用途 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001335598A (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2383592A1 (en) * | 1999-03-31 | 2000-10-05 | Curagen Corporation | 2384891 acids including open reading frames encoding polypeptides; orfx |
-
2001
- 2001-03-23 JP JP2001084088A patent/JP2001335598A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002536338A (ja) | アポトーシスを活性化するｔｎｆ相同物、ｔｈａｎｋの利用 | |
| JP2004511253A5 (enExample) | ||
| RU2003130638A (ru) | Протеин, связанный с заболеванием | |
| JP2004500125A5 (enExample) | ||
| JP2002517193A5 (enExample) | ||
| JP2002533115A5 (enExample) | ||
| ATE249236T1 (de) | Prädiktive und therapeutische für nierenerkrankungen gene und proteine | |
| JP2005528080A5 (enExample) | ||
| WO2000001820A2 (en) | Nucleic acid molecules encoding nuclear hormone receptor coactivators, and uses thereof | |
| JP2001335598A5 (enExample) | ||
| US20030211514A1 (en) | Apoptosis-inducing factor | |
| AU774355B2 (en) | Novel bag proteins and nucleic acid molecules encoding them | |
| JP2002345468A5 (enExample) | ||
| JP3801565B2 (ja) | 肥満を治療または抑制する組成物 | |
| JP2004533235A5 (enExample) | ||
| JP2002508934A (ja) | Ｔｎｆレセプターに対して相同性を有する、新規な核酸およびポリペプチド | |
| EP1131434B1 (en) | Apoptosis-inducing factor | |
| JP2008509659A5 (enExample) | ||
| Zarivach et al. | Initiation and inhibition of protein biosynthesis-Studies at high resolution | |
| JP2005506833A5 (enExample) | ||
| JP2004533202A (ja) | ２２個のヒト分泌タンパク質 | |
| CN1863548A (zh) | 治疗细胞外基质紊乱的方法和组合物 | |
| JP2003061662A5 (enExample) | ||
| JP2003315332A5 (enExample) | ||
| JP2001069994A5 (enExample) |